Deferasirox
- Product NDC
- 69539-073
- 11-digit product format
- 695390073
- Labeler code
- 69539
- Product ID
- 69539-073_da168049-e499-4563-afe8-82ae754ed640
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Deferasirox
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- MSN LABORATORIES PRIVATE LIMITED
- Application
- ANDA210945
- Marketing category
- ANDA
- Marketing start
- 2019-11-20
- Substance
- DEFERASIROX
- Active strength
- 90 mg/1
- Pharmacologic classes
- Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 69539-073-30 | Deferasirox | 30 in 1 BOTTLE | TABLET | 30 | | 7 |
| 69539-073-99 | Deferasirox | 1000 in 1 BOTTLE | TABLET | 1000 | | 7 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69539-073 | DEFERASIROX TABLET [MSN LABORATORIES PRIVATE LIMITED] | 7 | Current NDC, Legacy NDC, 2 package rows | 20210109_0354cbc7-9b32-4513-976a-2ef2da39b6b3.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69539-073-30 | 69539007330 | 30 TABLET in 1 BOTTLE (69539-073-30) | 30 tablet | 2019-11-20 | 0000-00-00 | No | No | Current |
| 69539-073-99 | 69539007399 | 1000 TABLET in 1 BOTTLE (69539-073-99) | 1000 tablet | 2019-11-20 | 0000-00-00 | No | No | Current |